Skip to main content

Table 3 Antibiotic resistance pattern to P. Aeruginosa

From: Chitosan-casein as novel drug delivery system for transferring Phyllanthus emblica to inhibit Pseudomonas aeruginosa

Class

Symbol

Antimicrobial Agent

Disk content (µg)

Susceptible (S)

Intermediate(I)

Resistant(R)

Number of resistant strains

Percentage of resistant strains

Total

Carbapenems

IMI

Imipenem

10 µg

≥ 22

19–21

18 ≥

10

100%

10 Strain

Ureidopenicillins

PTZ

Piperacillin-tazobactam

100/10µg

≥ 21

18–20

17 ≥

5

50%

Sulfonamide + inhibitor

SAM

Ampicillin-sulbactam

10 µg + 10 µg

≥ 15

12–14

11 ≥

6

60%

Aminoglycosides

K

Kanamycin

30 µg

≥ 17

15–16

14≥

9

90%

Cephalosporins

CAZ

Ceftazidime

30 µg

≥ 18

15–17

14 ≥

7

70%

FEP

Cefepime

30 µg

≥ 18

15–17

14 ≥

3

30%

Colistin

COL

Colistin

10 µg

2≥

-

≥ 4

4

40%

Quinolones

CIP

Ciprofloxacin

5 µg

≥ 17

15–16

14≥

3

30%